JP2017524337A5 - - Google Patents

Download PDF

Info

Publication number
JP2017524337A5
JP2017524337A5 JP2016567242A JP2016567242A JP2017524337A5 JP 2017524337 A5 JP2017524337 A5 JP 2017524337A5 JP 2016567242 A JP2016567242 A JP 2016567242A JP 2016567242 A JP2016567242 A JP 2016567242A JP 2017524337 A5 JP2017524337 A5 JP 2017524337A5
Authority
JP
Japan
Prior art keywords
seq
peptide
antigen
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016567242A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017524337A (ja
JP6659582B2 (ja
Filing date
Publication date
Priority claimed from GBGB1408255.6A external-priority patent/GB201408255D0/en
Application filed filed Critical
Publication of JP2017524337A publication Critical patent/JP2017524337A/ja
Publication of JP2017524337A5 publication Critical patent/JP2017524337A5/ja
Application granted granted Critical
Publication of JP6659582B2 publication Critical patent/JP6659582B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016567242A 2014-05-09 2015-05-08 急性骨髄性白血病(aml)などの血液のいくつかの腫瘍に対する新規免疫療法 Expired - Fee Related JP6659582B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201461990980P 2014-05-09 2014-05-09
GBGB1408255.6A GB201408255D0 (en) 2014-05-09 2014-05-09 Novel immunotherapy against several tumours of the blood, such as acute myeloid leukemia (AML)
US61/990,980 2014-05-09
GB1408255.6 2014-05-09
PCT/EP2015/060168 WO2015169945A2 (en) 2014-05-09 2015-05-08 Novel immunotherapy against several tumors of the blood, such as acute myeloid leukemia (aml)

Publications (3)

Publication Number Publication Date
JP2017524337A JP2017524337A (ja) 2017-08-31
JP2017524337A5 true JP2017524337A5 (cg-RX-API-DMAC7.html) 2019-10-03
JP6659582B2 JP6659582B2 (ja) 2020-03-04

Family

ID=51032516

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016567242A Expired - Fee Related JP6659582B2 (ja) 2014-05-09 2015-05-08 急性骨髄性白血病(aml)などの血液のいくつかの腫瘍に対する新規免疫療法

Country Status (25)

Country Link
US (2) US10064924B2 (cg-RX-API-DMAC7.html)
EP (3) EP3449937A1 (cg-RX-API-DMAC7.html)
JP (1) JP6659582B2 (cg-RX-API-DMAC7.html)
KR (1) KR20170003976A (cg-RX-API-DMAC7.html)
CN (1) CN106459167A (cg-RX-API-DMAC7.html)
AU (2) AU2015257652B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016025035A2 (cg-RX-API-DMAC7.html)
CA (1) CA2946349A1 (cg-RX-API-DMAC7.html)
CR (1) CR20160531A (cg-RX-API-DMAC7.html)
DK (1) DK3140319T3 (cg-RX-API-DMAC7.html)
EA (2) EA035456B1 (cg-RX-API-DMAC7.html)
ES (1) ES2747734T3 (cg-RX-API-DMAC7.html)
GB (1) GB201408255D0 (cg-RX-API-DMAC7.html)
HU (1) HUE045177T2 (cg-RX-API-DMAC7.html)
LT (1) LT3140319T (cg-RX-API-DMAC7.html)
MA (3) MA49280A (cg-RX-API-DMAC7.html)
ME (1) ME03565B (cg-RX-API-DMAC7.html)
MX (1) MX2016014711A (cg-RX-API-DMAC7.html)
PL (1) PL3140319T3 (cg-RX-API-DMAC7.html)
PT (1) PT3140319T (cg-RX-API-DMAC7.html)
RS (1) RS59471B1 (cg-RX-API-DMAC7.html)
SG (1) SG11201608332SA (cg-RX-API-DMAC7.html)
SI (1) SI3140319T1 (cg-RX-API-DMAC7.html)
TW (2) TWI668230B (cg-RX-API-DMAC7.html)
WO (1) WO2015169945A2 (cg-RX-API-DMAC7.html)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
US10000533B2 (en) * 2014-06-20 2018-06-19 Immatics Biotechnologies Gmbh Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
MX392028B (es) 2015-05-13 2025-03-04 Agenus Inc Vacunas para el tratamiento y prevención del cáncer.
GB201521746D0 (en) 2015-12-10 2016-01-27 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers
GB201521894D0 (en) * 2015-12-11 2016-01-27 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against various cancers
EP3389630B1 (en) 2015-12-16 2023-11-08 Gritstone bio, Inc. Neoantigen identification, manufacture, and use
SG10202111399YA (en) 2015-12-22 2021-11-29 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
GB201603987D0 (en) * 2016-03-08 2016-04-20 Immatics Biotechnologies Gmbh Uterine cancer treatments
GB201604458D0 (en) 2016-03-16 2016-04-27 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against cancers
US10357550B2 (en) 2016-04-06 2019-07-23 Immatics Biotechnologies Gmbh Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
KR102411975B1 (ko) * 2016-04-06 2022-06-22 이매틱스 바이오테크놀로지스 게엠베하 Aml 및 다른 암에 대한 면역요법에 사용하기 위한 펩티드 및 펩티드의 조합
KR20180132807A (ko) * 2016-04-07 2018-12-12 케이스 웨스턴 리저브 유니버시티 신경퇴행성 질환의 치료용 tdp-43 미토콘드리아 국소화 억제제
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
JP7075125B2 (ja) * 2016-05-25 2022-05-25 イマティクス バイオテクノロジーズ ゲーエムベーハー 標的としてのおよび胆嚢がんおよび胆管がんおよびその他のがんに対する免疫療法で使用するための新規ペプチド、ペプチド組み合わせ
MA45491A (fr) * 2016-06-27 2019-05-01 Juno Therapeutics Inc Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés
CN109863169A (zh) * 2016-08-23 2019-06-07 葛兰素史密丝克莱恩生物有限公司 具有连接至不变链(cd74)的短片段的抗原的融合肽
TWI796299B (zh) 2016-08-26 2023-03-21 德商英麥提克生物技術股份有限公司 用於頭頸鱗狀細胞癌和其他癌症免疫治療的新型肽和支架
DE102016123893A1 (de) 2016-12-08 2018-06-14 Immatics Biotechnologies Gmbh T-Zellrezeptoren mit verbesserter Bindung
EP4317432A3 (en) 2016-12-08 2024-04-17 Immatics Biotechnologies GmbH T cell receptors with improved pairing
TW201841937A (zh) 2017-04-10 2018-12-01 德商英麥提克生物技術股份有限公司 用於白血病和其他癌症免疫治療的新穎肽和肽組合物
US20200376028A1 (en) * 2017-04-10 2020-12-03 Yoram Palti Methods and Compounds for Treating Diabetes
BR112019021094A2 (pt) 2017-04-10 2020-05-12 Immatics Biotechnologies Gmbh Peptídeos e combinações dos mesmos para uso na imunoterapia contra leucemias e outros cânceres
JP7227237B2 (ja) 2017-10-10 2023-02-21 グリットストーン バイオ インコーポレイテッド ホットスポットを利用した新生抗原の特定
CA3083242A1 (en) * 2017-11-21 2019-05-31 Naofumi MIWA Human cancer cell metastasis inhibitory agent and human cancer cell determination agent
CN111630602A (zh) 2017-11-22 2020-09-04 磨石肿瘤生物技术公司 减少新抗原的接合表位呈递
CA3096909A1 (en) 2018-04-26 2019-10-31 Agenus Inc. Heat shock protein-binding peptide compositions and methods of use thereof
CN108707666B (zh) * 2018-05-28 2021-04-09 陕西中医药大学第二附属医院 Dgkz基因作为白血病检测的生物标志物的应用
CN109663128A (zh) * 2018-11-21 2019-04-23 中国农业大学 一种肺动脉高压标志物及其作为治疗靶点的应用
AU2020232971A1 (en) * 2019-03-01 2021-09-23 Scott R. BURKHOLZ Design, manufacture, and use of personalized cancer vaccines
CN112409449B (zh) * 2019-08-19 2023-12-15 辽宁中健医药科技有限公司 Hla-a0201限定性kif15特异性抗肿瘤ctl优势表位肽及应用
WO2021207823A1 (en) * 2020-04-14 2021-10-21 Université de Montréal Novel tumor-specific antigens for acute myeloid leukemia (aml) and uses thereof
CN112980955A (zh) * 2021-03-05 2021-06-18 南昌大学第二附属医院 Emilin2作为胶质瘤替莫唑胺耐药检测、治疗及预后分子靶点的应用
CN113130001B (zh) * 2021-03-31 2023-07-18 甘肃中医药大学 一种天然化合物与抗肿瘤化合物配伍的筛选方法
EP4334332A4 (en) * 2021-05-04 2025-11-12 California Inst Of Techn VAA RECOMMENDANTS FOR ADMINISTRATION TO THE CENTRAL NERVOUS SYSTEM AND CEREBRAL VASCULATURE
JP2024534825A (ja) * 2021-08-24 2024-09-26 イマティクス ユーエス,アイエヌシー. 条件付きリガンド交換により産生されたペプチドmhc複合体を使用する免疫細胞の選択
CN114703274B (zh) * 2022-04-01 2023-08-15 中国人民解放军总医院 Phpt1在预警和/或治疗高原病中的应用
CN117586344B (zh) * 2022-08-12 2025-07-25 上海交通大学医学院附属瑞金医院 靶向flt3-d835突变的抗原肽及其在肿瘤免疫治疗中的应用
WO2025011658A1 (en) * 2023-07-12 2025-01-16 Anda Biology Medicine Development (Shenzhen) Co., Ltd Novel markers for tumor neoantigen vaccines

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440859A (en) 1977-05-27 1984-04-03 The Regents Of The University Of California Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms
US4704362A (en) 1977-11-08 1987-11-03 Genentech, Inc. Recombinant cloning vehicle microbial polypeptide expression
BR7908410A (pt) 1978-12-22 1980-09-09 Biogen Nv Meio para deteccao de anticorpos de vhb no soro do sangue,e processo para deteccao da presenca da infeccao por virus da hepatite b em seres humanos
US4530901A (en) 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
US4342566A (en) 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
US4678751A (en) 1981-09-25 1987-07-07 Genentech, Inc. Hybrid human leukocyte interferons
US4766075A (en) 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
US4582800A (en) 1982-07-12 1986-04-15 Hoffmann-La Roche Inc. Novel vectors and method for controlling interferon expression
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4757006A (en) 1983-10-28 1988-07-12 Genetics Institute, Inc. Human factor VIII:C gene and recombinant methods for production
US4677063A (en) 1985-05-02 1987-06-30 Cetus Corporation Human tumor necrosis factor
US4810648A (en) 1986-01-08 1989-03-07 Rhone Poulenc Agrochimie Haloarylnitrile degrading gene, its use, and cells containing the gene
US4897445A (en) 1986-06-27 1990-01-30 The Administrators Of The Tulane Educational Fund Method for synthesizing a peptide containing a non-peptide bond
DE69420137T2 (de) 1993-06-03 1999-12-23 Therapeutic Antibodies, Inc. Herstellung von antikörperfragmenten
AUPM322393A0 (en) 1993-12-24 1994-01-27 Austin Research Institute, The Mucin carbohydrate compounds and their use in immunotherapy
WO1997026328A1 (en) 1996-01-17 1997-07-24 Imperial College Innovations Limited Immunotherapy using cytotoxic t lymphocytes (ctl)
US5849589A (en) 1996-03-11 1998-12-15 Duke University Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
AU7033400A (en) * 1999-08-30 2001-03-26 Jehad Mikhaiel Charo Induction of cytotoxic t lymphocyte response by hla class ia restricted epitopesof mycobacterial heat shock protein 65
EP2169073B1 (en) * 1999-10-11 2013-11-13 Institut Pasteur Vector for the preparation of immunotherapeutical compositions
AU2087401A (en) * 1999-12-10 2001-06-18 Epimmune, Inc. Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions
WO2001070955A2 (en) * 2000-03-21 2001-09-27 Elitra Pharmaceuticals, Inc. Identification of essential genes in prokaryotes
CA2404489A1 (en) 2000-03-27 2001-10-04 Technion Research And Development Foundation Ltd. Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same
US20040191260A1 (en) 2003-03-26 2004-09-30 Technion Research & Development Foundation Ltd. Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
US7834146B2 (en) * 2000-05-08 2010-11-16 Monsanto Technology Llc Recombinant polypeptides associated with plants
CN101712721A (zh) 2000-06-05 2010-05-26 阿尔托生物科学有限公司 T细胞受体融合物及共轭物以及其使用方法
EP1451305A4 (en) * 2001-11-07 2005-10-05 Mannkind Corp EPITOPE SYNCHRONIZATION IN CELLS THAT HAVE ANTIGENS
US6992176B2 (en) 2002-02-13 2006-01-31 Technion Research & Development Foundation Ltd. Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
EP1485075A4 (en) 2002-02-20 2006-04-26 Dyax Corp MHC-PEPTIDE COMPLEX BINDING LIGANDS
CA2501870C (en) 2002-10-09 2013-07-02 Avidex Limited Single chain recombinant t cell receptors
AU2003276403B2 (en) 2002-11-09 2010-04-15 Adaptimmune Limited T cell receptor display
GB0304068D0 (en) 2003-02-22 2003-03-26 Avidex Ltd Substances
KR100692416B1 (ko) * 2003-05-26 2007-03-09 학교법인 배재학당 Faf1 단편 및 그를 함유하는 종양 전이 억제제
EP2368906A1 (en) 2004-04-29 2011-09-28 SK Corp. Fas associated factor 1
US7314630B2 (en) * 2005-01-07 2008-01-01 Yao-Xiong Hu Compounds and methods of early diagnosis of cervical cancer and genital condyloma with HPV, CHSP60 tumor suppressor H-Ras, K-Ras and PTEN derived peptides modified
SI1806359T1 (sl) * 2005-09-05 2010-06-30 Immatics Biotechnologies Gmbh S tumorjem povezani peptidi ki se vežejo brez izjeme na molekule humanega levkocitnega antigena HLA razred II
PL3042914T3 (pl) * 2007-07-27 2019-01-31 Immatics Biotechnologies Gmbh Nowe immunogenne epitopy do immunoterapii
ES2342506T3 (es) 2008-04-30 2010-07-07 Immatics Biotechnologies Gmbh Novedosas formulaciones para vacunas de peptidos asociados a tumores, unidos a moleculas del antigeno de leucocito humano (hla) de clase i o ii.
GB201004551D0 (en) * 2010-03-19 2010-05-05 Immatics Biotechnologies Gmbh NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
GB201006360D0 (en) 2010-04-16 2010-06-02 Immatics Biotechnologies Gmbh Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development
KR101224466B1 (ko) * 2010-05-20 2013-01-22 가톨릭대학교 산학협력단 토포아이소머라아제 2 알파 유래의 종양항원 단백질, 유전자, 또는 펩타이드
BR112013010213A2 (pt) 2010-10-26 2019-09-24 Technion Research & Development Foundation Ltd anticorpos que unem ligantes solúveis de receptores de célula t
WO2013057586A1 (en) 2011-10-19 2013-04-25 Oslo Universitetssykehus Hf Compositions and methods for producing soluble t - cell receptors
GB201411037D0 (en) * 2014-06-20 2014-08-06 Immatics Biotechnologies Gmbh Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemai (CLL)

Similar Documents

Publication Publication Date Title
JP2017524337A5 (cg-RX-API-DMAC7.html)
JP2017525336A5 (cg-RX-API-DMAC7.html)
JP7668742B2 (ja) Mhcクラスiiモデルによる新生抗原の特定
JP7480064B2 (ja) パンアレルモデルによる新生抗原の特定方法
JP7763588B2 (ja) T細胞療法用の新生抗原の特定法
JP5182770B2 (ja) Mhc分子を結合する腫瘍関連ペプチド
JP2025143480A (ja) ホットスポットを利用した新生抗原の特定
JP2018529320A5 (cg-RX-API-DMAC7.html)
JP2018511321A5 (cg-RX-API-DMAC7.html)
JP2018509135A5 (cg-RX-API-DMAC7.html)
JP2019510465A5 (cg-RX-API-DMAC7.html)
JP2018536383A5 (cg-RX-API-DMAC7.html)
JP2018510628A5 (cg-RX-API-DMAC7.html)
JP2019502360A5 (cg-RX-API-DMAC7.html)
JP2018518937A5 (cg-RX-API-DMAC7.html)
JP2018520653A5 (cg-RX-API-DMAC7.html)
JP2018519243A5 (cg-RX-API-DMAC7.html)
JP7034931B2 (ja) ネオエピトープのウイルス送達のための改善された組成物および方法ならびにその使用
JP2018521641A5 (cg-RX-API-DMAC7.html)
JP2019506838A5 (cg-RX-API-DMAC7.html)
JP2017502076A5 (cg-RX-API-DMAC7.html)
JP7051898B2 (ja) 標的型ネオエピトープベクター及びそのための方法
JP2019513021A (ja) ネオエピトープ提示のための配列の配置および配列
AU2017362730B2 (en) Fractal combination therapy
JP2020530759A5 (cg-RX-API-DMAC7.html)